A note on the Amazon ads: I've chosen to display current events titles in the Amazon box. Unfortunately, Amazon appears to promote a disproportionate number of angry-left books. I have no power over it at this time. Rest assured, I'm still a conservative.
|
Wednesday, April 24, 2002
If you want to know what's really going on in the scientific field regarding stem cell research, don't count on finding it in the mainstream media. Kudos to the National Review and Wesley J. Smith for collecting information about beneficial adult stem cell research.
Interesting and telling factoid:
How many humans have been treated by embryonic stem cells? Zero. Indeed, before human trials can even be safely undertaken researchers will have to overcome two serious difficulties that stand between patients and embryonic-cell regenerative medicine: 1) ES cells cause tumors, and 2) ES cells may be rejected by the immune system. Surmounting these difficulties — if they can be surmounted at all — will take a very long time and much expense. There is no risk of rejection with adult cells, by contrast, because they come from the patients' own bodies. Nor, at least so far, does adult-stem-cell therapy appear to cause tumors. This puts adult therapies years ahead of the game.
You'd think that journalists would be praising the successful adult stem cell research and treatment that's going on, and panning the beleaguered embryonic stem cell research. Unfortunately the opposite is true.
1:14 AM
|
|
